Comments on the proposed ICMJE Disclosure Form

Return to ICMJE

Displaying 71 - 75 of 129 comments
  • Leslie Avant
    Role(s):
    Date Submitted: Friday, March 20, 2020 - 15:40

  • Richard Schreiber MD
    Geisinger Health System
    Role(s):
    • An author who publishes work in medical journals
    • A health care professional
    • A patient
    • A reader of medical journals
    • A journal editor
    Date Submitted: Thursday, March 19, 2020 - 11:26

    It is easy to understand what the ICMJE Disclosure Form is asking to be disclosed.
    • Yes
    Comments: The form seems straightforward and easy to comprehend. I also like the proposal to use web based repositories to collect and report the ICMJE requirements.

    The information collected by the ICMJE Disclosure Form is appropriate.
    • Yes

  • Neil Navarrez
    Role(s): A health care professional
    Date Submitted: Wednesday, March 18, 2020 - 11:41

    It is easy to understand what the ICMJE Disclosure Form is asking to be disclosed.
    • Yes

    The information collected by the ICMJE Disclosure Form is appropriate.
    • Yes

  • Daniela Finizio
    Freelance
    Role(s): Other
      • authors editor
    Date Submitted: Friday, March 13, 2020 - 11:06

    It is easy to understand what the ICMJE Disclosure Form is asking to be disclosed.
    • Yes

    The information collected by the ICMJE Disclosure Form is appropriate.
    • No
    Comments: I feel authours may be reluctant to enter in such a level of details. I would rather create broader categories

  • Andrea Cifelli on behalf of Envision Pharma Group
    Envision Pharma Group
    Role(s): Other
    Date Submitted: Tuesday, March 10, 2020 - 07:55

    It is easy to understand what the ICMJE Disclosure Form is asking to be disclosed.
    • No
    Comments: The distinctions between “directly-related” and “topically-related” will vary based on topics of publication and may need to be defined more clearly, as noted in previous comments. Based on the instructions, it seems that a disclosure can be either directly related or topically related, but not both. This may be misunderstood, with authors potentially selecting both categories. A more intuitive way of presenting these categories may help. In the second column of the form, are authors supposed to specify all relationships/activities, not just list the company that they have the relationship with? This is not quite clear. Furthermore, guidance on how to report disclosures for an individual author vs disclosure for their institution(s) should be provided. Some of the wording is ambiguous or difficult to understand for non-native English speakers (for example ‘fiduciary’ or ‘topical’) and should be replaced with plain language terms. It may be useful to state explicitly that all financial relationships, regardless of monetary amount, should be declared to prevent non-disclosure of smaller amounts, which may appear ‘negligible’ to authors. Finally, in addition to previous comments, please note that there is no obvious option for present and (recent) past employment as a conflict of interest.

    The information collected by the ICMJE Disclosure Form is appropriate.
    • No
    Comments: Some forms of support should not be grouped together (e.g., receipt of materials and receipt of writing), as disclosure of writing support may easily be overlooked if presented in this way. We suggest ‘writing’ to be a separate category and for the term to be expanded to include other types of support, i.e., change ‘writing’ to ‘medical writing/editorial support’ (which includes writing, figure preparation, copy-editing, proof-reading, etc). Furthermore, we suggest the inclusion of open-access fees (often paid for by sponsors) as a form of support to be disclosed. We suggest the addition shown in bold underlined font below to the following statement: Although the existence of a relationship or activity may not represent a problematic influence on your work, a complete listing helps to reassure readers of your commitment to transparency and is required by Good Publication Practice (GPP) guidelines. Will this form be translated into other languages? This may be particularly important for authors from the Asia-Pacific region. Will there be an auto-generated disclosure that is generated from the form? The previous version did this and the auto-generated disclosure summary did not always read as clearly as what was entered into the form.

Pages